Definitive Contract VA24717C0065
- Not listed
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract, which has a potential value of $883,594.79, is a Blanket Purchase Agreement (BPA) call under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide COVID-19 testing reagents. The $223,560 firm fixed-price purchase order has a completion date of September 30, 2021. Biofire Diagnostics LLC has received numerous federal contracts to supply infectious disease testing products and services, including molecular diagnostic testing, reagents, and maintenance...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The contract is a Blanket Purchase Agreement (BPA) call order under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The contract has a potential value of $297,026.26 and a...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a Delivery Order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide EMERGENCY BIOFIRE FILM ARRAY diagnostic products. The $210,076.64 firm-fixed-price contract supports the Coronavirus COVID-19 National Interest Action and was issued against Biofire's existing GSA Federal Supply Schedule contract for in-vitro diagnostics. Biofire Diagnostics is a leader in syndromic infectious...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in infectious disease testing. The $110,160.00 firm-fixed-price purchase order was issued under the VA VISN 9 network for COVID-19 panel testing using Biofire's 423738 COVID emergency testing products. No set-aside was used. Biofire Diagnostics has held numerous federal contracts with the VA,...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $121,440.00 firm fixed-price contract is for the provision of BIOFIRE diagnostic products and services, issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents,...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration (VA VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company. The $174,974.00 Blanket Purchase Agreement (BPA) Call contract is for medical cost per test services, with a firm fixed price pricing type. The contract has no set-aside designation. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received multiple awards from the VA...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Blanket Purchase Agreement (BPA) call to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide virus, bacteria, and parasite detection systems. The contract has a potential value of $241,860.00 and is not set-aside. Biofire Diagnostics specializes in syndromic infectious disease testing and has received numerous federal contracts to provide molecular diagnostic testing services,...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. The contract, valued at $3,679,381.66, is for the provision of reagents on a cost-per-test basis. The contract was awarded on March 23, 2017, with a completion date of August 16, 2022, and is associated with the Coronavirus COVID-19 national interest action. The contract is a firm-fixed-price arrangement with no set-aside designation. Biofire Diagnostics LLC has held multiple indefinite delivery contracts and blanket purchase agreements with the VA VHA and other federal agencies, including the Defense Health Agency, Department of Health and Human Services Indian Health Service, and Department of State, to provide infectious disease testing products and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00019 | Other Administrative Action | ($34k) | 8/16/22 | |
| P00016 | Exercise an Option | $629.4k | 4/6/21 | |
| P00015 | Other Administrative Action | ($7k) | 10/29/20 | |
| P00014 | Other Administrative Action | $999.9k | 9/26/20 | |
| P00013 | Other Administrative Action | ($1000k) | 9/26/20 |